Hypercalcemia is fairly common among patients receiving dialysis. Retention of phosphate among these patients promotes hyperparathyroidism, raising calcium levels. In addition, dialysis patients have lower concentrations of 1,25-dihydroxvitamin D levels and higher levels of resistance to fibroblast growth factor 23.